HighTower Advisors LLC Has $15.70 Million Holdings in Encompass Health Corporation $EHC

HighTower Advisors LLC increased its position in shares of Encompass Health Corporation (NYSE:EHC) by 804.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 155,318 shares of the company’s stock after purchasing an additional 138,145 shares during the quarter. HighTower Advisors LLC’s holdings in Encompass Health were worth $15,700,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the company. Northwestern Mutual Wealth Management Co. raised its position in Encompass Health by 3,059,159.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock valued at $402,640,000 after purchasing an additional 3,793,358 shares in the last quarter. AlphaCore Capital LLC bought a new position in shares of Encompass Health in the 4th quarter valued at $4,881,000. Ancora Advisors LLC acquired a new position in shares of Encompass Health during the 2nd quarter worth $10,639,000. Systematic Financial Management LP lifted its position in shares of Encompass Health by 3.6% during the 4th quarter. Systematic Financial Management LP now owns 440,752 shares of the company’s stock worth $46,782,000 after buying an additional 15,462 shares during the last quarter. Finally, Trillium Asset Management LLC boosted its stake in Encompass Health by 5.7% in the fourth quarter. Trillium Asset Management LLC now owns 217,734 shares of the company’s stock valued at $23,424,000 after buying an additional 11,793 shares in the last quarter. 97.25% of the stock is owned by institutional investors.

Analysts Set New Price Targets

EHC has been the subject of several research analyst reports. Truist Financial boosted their target price on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Barclays increased their price objective on shares of Encompass Health from $140.00 to $144.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. UBS Group boosted their target price on shares of Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Leerink Partners set a $152.00 price target on shares of Encompass Health in a report on Friday, May 22nd. Finally, Wall Street Zen cut Encompass Health from a “buy” rating to a “hold” rating in a research note on Saturday, September 5th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $146.83.

Encompass Health Trading Up 0.9%

EHC opened at $121.52 on Thursday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.19 and a quick ratio of 1.19. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99. The company’s 50 day moving average price is $116.54 and its two-hundred day moving average price is $107.83. The firm has a market capitalization of $11.99 billion, a price-to-earnings ratio of 19.79, a PEG ratio of 2.44 and a beta of 0.75.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.07. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The firm had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter last year, the firm earned $1.40 earnings per share. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. As a group, research analysts predict that Encompass Health Corporation will post 6.08 earnings per share for the current year.

Encompass Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be given a $0.21 dividend. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date is Thursday, October 1st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio is presently 12.38%.

Insider Transactions at Encompass Health

In other news, CEO Mark J. Tarr sold 173,148 shares of the company’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $125.47, for a total value of $21,724,879.56. Following the sale, the chief executive officer directly owned 267,814 shares of the company’s stock, valued at approximately $33,602,622.58. This represents a 39.27% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP John Darby sold 4,858 shares of the business’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $121.09, for a total transaction of $588,255.22. Following the completion of the transaction, the executive vice president owned 75,041 shares in the company, valued at approximately $9,086,714.69. The trade was a 6.08% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 186,912 shares of company stock worth $23,434,845 in the last quarter. Corporate insiders own 1.80% of the company’s stock.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.